Movement Disorders in Post Stroke Patients: A Retrospective Analysis
Objective: To review the prevalence of various movement disorders in post stroke patients at a tertiary, academic center and to characterize the therapeutic response to…Agreement Between the GAITRite® Walkway System and the Wearable Inertial Sensor BTS G-Walk® for Measurement of Gait Parameters
Objective: The aim of this study was to compare two systems for gait measurement (GAITRite G-Walk system) and to assess their agreement for measurement of…Trends in first line therapy for PD in Wales: A 16 year observational study
Objective: To examine the changes in first line therapy of newly diagnosed Parkinson’s patients between 2000 and 2016 in Wales. Background: There have been several…Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study
Objective: To characterize the genetic and biomarker profile of patients with Progressive Supranuclear Palsy (PSP) and the relationship of potential biomarkers with baseline disease severity.…Validation of the diagnostic criteria for progressive supranuclear palsy in pathologically confirmed patients
Objective: To assess the sensitivity and specificity of the diagnostic criteria for progressive supranuclear palsy (PSP). Background: The International Parkinson and Movement Disorder Society criteria…Identifying perceptual, motor and cognitive components contributing to the slowness of information processing in Parkinson’s disease and the implication in the quality of life
Objective: To identify, through tasks of reaction times (RT), the motor, cognitive and perceptual components involved in the processing of information in PD and to…Cholecalciferol (VD3) attenuated motor deficits and dyskinesia in Hemi-Parkinsonian mice: behavioural, biochemical & electrophysiological implications
Objective: The study investigated the impacts of VD3 on behavioural indices, dopamine metabolism, DA transport, BDNF, corticostriatal neural activities and the possible mechanism of action…Evaluation of dose rate of photobiomodulation (light) therapy in patients with Parkinson’s Disease: Double blind placebo-controlled pilot trial. Is there a dose frequency per week that influences quality of life, mobility and cognition?
Objective: This assessor- and participant-blinded placebo-controlled pilot study aimed to evaluate the influence on motor outcomes associated with Parkinson’s Disease with different dose application regimens…Characteristics of gait and quality of life in Parkinson’s disease
Objective: To find the independent correlation between characteristics of gait and QoL in PD, comprehensive assessment of clinical characteristics and objective gait analyses were done…Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders
Objective: This systematic review provides an overview of behavioral and event-related potential (ERP) studies investigating central auditory processing in patients with Parkinson’s disease (PD), progressive…
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 217
- Next Page »